VFM
AZN icon

Vision Financial Markets’s AstraZeneca AZN Stock Holding History

Vision Financial Markets’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Hold
76
– – 0.01% 221
2026
Q1 		$15K Sell
76
-1
-1% -$193 0.01% 204
2025
Q4 		$14K Hold
77
– – 0.01% 198
2025
Q3 		$11.7K Buy
77
+1
+1% +$151 0.01% 236
2025
Q2 		$10.6K Hold
76
– – 0.01% 229
2025
Q1 		$11.2K Hold
76
– – 0.01% 205
2024
Q4 		$9.91K Buy
+76
New +$10.6K 0.01% 181

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Vision Financial Markets's AZN Position: Q2 2026 in Review

Vision Financial Markets held its AstraZeneca (AZN) position steady in Q2 2026 at 76 shares worth $14.3K. The position accounts for 0.01% of the portfolio, ranked #221.

Vision Financial Markets first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $15K in Q1 2026. 555 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Vision Financial Markets held 76 shares of AstraZeneca worth $14.3K as of Q2 2026.
  • Vision Financial Markets left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.01% of Vision Financial Markets's portfolio in Q2 2026, its #221 holding.
  • Vision Financial Markets first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Vision Financial Markets's AstraZeneca position peaked at $15K in Q1 2026.
  • 555 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.